Evidence map›Paper›PMID 34807831›Full record

ArticleJMIR mental health2021

Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study.

Isabell Paetzold, Karlijn S F M Hermans, Anita Schick, Barnaby Nelson, Eva Velthorst, Frederike Schirmbeck, EU-GEI High Risk Study, Jim van Os, Craig Morgan, Mark van der Gaag and 6 more

Abstract read
In one paragraph

Article in JMIR mental health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Isabell PaetzoldDepartment of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-4054-4331
Karlijn S F M HermansDepartment of Neuroscience, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.ORCID 0000-0003-3570-6479
Anita SchickDepartment of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-2043-0353
Barnaby NelsonOrygen, Parkville, Victoria, Australia.ORCID 0000-0002-6263-2332
Eva VelthorstDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0002-9240-2909
Frederike SchirmbeckDepartment of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-1700-0958
EU-GEI High Risk Study *See Acknowledgments, Maastricht, Netherlands.
Jim van OsDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.ORCID 0000-0002-7245-1586
Craig MorganESRC Centre for Society and Mental Health, King's College London, London, United Kingdom.ORCID 0000-0002-1386-2369
Mark van der GaagDepartment of Clinical, Neuro and Developmental Psychology, Vrije Universiteit, Amsterdam, Netherlands.ORCID 0000-0002-3525-6415
Lieuwe de HaanDepartment of Early Psychosis, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-3820-7926
Lucia ValmaggiaDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.ORCID 0000-0001-6099-8464
Philip McGuireDepartment of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.ORCID 0000-0003-4381-0532
Matthew KemptonDepartment of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.ORCID 0000-0003-3541-9947
Inez Myin-GermeysDepartment of Neuroscience, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.ORCID 0000-0002-3731-4930
Ulrich ReininghausDepartment of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-9227-5436

Funding

Medical Research Council MR/J008915/1Wellcome Trust
6 · The paper itself

Abstract

backgroundNegative symptoms occur in individuals at ultrahigh risk (UHR) for psychosis. Although there is evidence that observer ratings of negative symptoms are associated with level of functioning, the predictive value of subjective experience in daily life for individuals at UHR has not been studied yet.

objectiveThis study therefore aims to investigate the predictive value of momentary manifestations of negative symptoms for clinical outcomes in individuals at UHR.

methodsExperience sampling methodology was used to measure momentary manifestations of negative symptoms (blunted affective experience, lack of social drive, anhedonia, and social anhedonia) in the daily lives of 79 individuals at UHR. Clinical outcomes (level of functioning, illness severity, UHR status, and transition status) were assessed at baseline and at 1- and 2-year follow-ups.

resultsLack of social drive, operationalized as greater experienced pleasantness of being alone, was associated with poorer functioning at the 2-year follow-up (b=-4.62, P=.01). Higher levels of anhedonia were associated with poorer functioning at the 1-year follow-up (b=5.61, P=.02). Higher levels of social anhedonia were associated with poorer functioning (eg, disability subscale: b=6.36, P=.006) and greater illness severity (b=-0.38, P=.045) at the 1-year follow-up. In exploratory analyses, there was evidence that individuals with greater variability of positive affect (used as a measure of blunted affective experience) experienced a shorter time to remission from UHR status at follow-up (hazard ratio=4.93, P=.005).

conclusionsTargeting negative symptoms in individuals at UHR may help to predict clinical outcomes and may be a promising target for interventions in the early stages of psychosis.

Indexed as

ecological momentary assessmentpsychopathologypsychotic disorder

Identifiers

PMID34807831
PMCPMC8663470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.